Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
-1.png)
Simple, fast, accurate genetic testing solutions
Are you a pioneer pushing brave new frontiers in genetic testing? Together we can make personalized healthcare available to all. Our DNA test kits are fast, accurate, and easy to use – for the smoothest lab workflows. Join our journey!
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Hematology
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Cardiovascular diseases
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
News | June 26, 2025
Devyser launches Devyser HLA Loss: A high-precision NGS assay for post-transplant researchNews | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in China
Devyser secures SEK 8.9M five-year tender and strengthens Italian position
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Noninvasive fetal RHD testing is emerging as a standard of care: insights from a global survey
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
A workflow the team trusts: Several years of routine CFTR testing in a reproductive genetics lab in Germany
For many laboratories, CFTR testing is not an occasional add-on. It is part of a routine,...